Administración Nacional de Medicamentos, Alimentos y Tecnología Médica
Argentine regulator and PIC/S member; its current GMP guide is ANMAT Disposición 4159/2023.
WHAT ANMAT COVERS
The Administración Nacional de Medicamentos, Alimentos y Tecnología Médica regulates medicines, food, and medical technology in Argentina. Its current GMP guide for human-use medicines is Disposición ANMAT 4159/2023, which consolidated and replaced several earlier dispositions.
WHERE IT SITS INTERNATIONALLY
ANMAT is a PIC/S participating authority and builds its GMP guide on WHO, PIC/S, and ICH sources, making it one of the more internationally harmonised regulators in the region. For a CDMO or contract laboratory serving both Mercosur and export markets, that alignment means one quality system can generally satisfy both — provided local authorisation and language obligations are handled explicitly.
HOW ITS REQUIREMENTS BITE
ANMAT authorises establishments and products and inspects manufacturers supplying the Argentine market. As one of the longest-standing PIC/S members in the region, its inspection approach follows the PIC/S model, and its GMP guide is explicitly built on WHO, PIC/S, ICH, and ISO sources.
WHAT ANMAT PUBLISHES
- 01Disposición 4159/2023 — the consolidated GMP guide for medicines
- 02Farmacopea Argentina
- 03Dispositions covering registration, importation, and specific product categories
- 04Establishment and product authorisation records
- 05Safety alerts and recall notices
WHAT PRACTITIONERS GET WRONG
- ›Work from the consolidated Disposición 4159/2023, not the repealed dispositions it replaced — earlier texts still circulate in supplier files and audit packs.
- ›Argentina has been a PIC/S member since 2008 — among the earliest in Latin America, which is why its inspection style will feel familiar to anyone who has hosted an EU inspection.
- ›The guide is explicitly PIC/S- and ICH-aligned, so an EU- or PIC/S-compliant quality system maps closely; the gap is usually documentation language and local establishment authorisation, not technical requirements.
- ›Spanish-language documentation is expected, and translation quality is itself an inspection risk when a translated procedure diverges from the controlled original.
- ›Establishment authorisation and product registration are separate acts — a site can be authorised while a specific product is not yet registered.
ANMAT STANDARDS SPEQ DECODES · 1
DISCIPLINES IN ANMAT’S REMIT
Track ANMAT — and every regulator that matters
New rules, guidance, enforcement, and inspection signals from Administración Nacional de Medicamentos, Alimentos y Tecnología Médica and its peers worldwide, distilled into the free Weekly GxP Briefing.